Guggenheim Capital’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-83,807
| Closed | -$318K | – | 1970 |
|
|
2020
Q1 | $318K | Buy |
+83,807
| New | +$318K | ﹤0.01% | 1518 |
|
|
2017
Q4 | – | Sell |
-285,574
| Closed | -$2.1M | – | 2857 |
|
|
2017
Q3 | $2.1M | Buy |
285,574
+25,113
| +10% | +$185K | ﹤0.01% | 1620 |
|
|
2017
Q2 | $1.77M | Sell |
260,461
-12,340
| -5% | -$83.7K | ﹤0.01% | 1718 |
|
|
2017
Q1 | $2.58M | Buy |
+272,801
| New | +$2.58M | 0.01% | 1469 |
|